Pande Atul sold IMVT
July 24, 2026 · Form 4 insider transaction
Pande Atul sold 1,500 shares of Immunovant, Inc. at $39.80 per share, a transaction worth $59.7K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
1,500
Price
$39.80
Total value
$59.7K
InsiderPande Atul
Role—
CompanyImmunovant, Inc. (IMVT)
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJuly 24, 2026
Filing dateJuly 24, 2026
Shares owned after116,731
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on December 26, 2025.